From the shareholder letter it looks like NPAT for the half will be just under 2m (normalised 1.4m) giving a forwards P/E of 10 (if there is no growth) on the normalised figures but with barely any contribution to revenue from the acquisitions.
They also flagged some delays in projects in the half due to covid, so we could even have a stronger 2H22.
Seems good value here.
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.12M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $7.455K | 40.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33300 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 32135 | 1 |
View Market Depth
| Last trade - 15.03pm 29/07/2025 (20 minute delay) ? |
| AMO (ASX) Chart |